HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $28 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on MediWound (NASDAQ:MDWD) and maintained a price target of $28.
May 30, 2024 | 11:08 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on MediWound and maintained a price target of $28, indicating continued confidence in the company's prospects.
The reiteration of a Buy rating and maintenance of a $28 price target by HC Wainwright & Co. suggests strong confidence in MediWound's future performance. This positive analyst rating is likely to boost investor sentiment and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100